Carbonyl Scavenging for Traumatic Brain Injury

羰基清除治疗创伤性脑损伤

基本信息

  • 批准号:
    8795231
  • 负责人:
  • 金额:
    $ 32.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2018-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our laboratory has documented that generation of the potent reactive nitrogen species (RNS) peroxynitrite (PN) is responsible for oxidative damage by lipid peroxidation (LP) and neurotoxic protein modification by binding of LP-derived carbonyl-containing aldehydes such as 4-hydroxynoneal (4-HNE) and acrolein to mitochondrial and other cellular elements during the first 72 hrs after traumatic brain injury (TBI). This oxidative damage causes brain mitochondrial respiratory compromise and decreased calcium (Ca++) buffering which worsens post-TBI neuronal intracellular Ca++ overload, calpain-mediated neuronal cytoskeletal degradation, neurodegeneration and neurological impairment. Recently, a novel antioxidant approach for post-central nervous system (CNS) injury for decreasing, and possibly reversing, oxidative damage has been identified that involves scavenging the LP-derived carbonyl compounds ("carbonyl scavenging") preventing their neurotoxic effects. Preliminary support from other laboratories and our own has shown that certain clinically used drugs that contain hydrazine function groups can covalently bind to 4-HNE or acrolein and prevent their neurotoxicity. The proposed 3 Aim project will employ phenelzine, a long used hydrazine-containing anti-depressant that contains has been found to be an effective carbonyl scavenger, as a tool to investigate the antioxidant neuroprotective effects of carbonyl scavenging in isolated rat brain mitochondria and the rat controlled cortical impact TBI model. Specifcally, the project will define the neuroprotective pharmacology (e.g. mechanism of action, dose-response and therapeutic window) of phenelzine's "carbonyl scavenging" in terms of neuronal mitochondrial and cytoskeletal protection along with the ability to improve chronic motor and cognitive recovery and to decrease post-traumatic neurodegeneration. Since phenelzine has a long history of clinical use and a well understood human safety profile, the translation of the drug's use into clinical TBI trials would be facilitated.
描述(由申请人提供):我们的实验室已经证明,在创伤性脑损伤(TBI)后的最初72小时内,强效活性氮物种(RNS)过氧亚硝酸盐(PN)的产生负责脂质过氧化(LP)的氧化损伤和通过将LP衍生的含羰基醛(如4-羟基壬醛(4-HNE)和丙烯醛)结合到线粒体和其他细胞元素而对神经毒性蛋白进行修饰。这种氧化损伤

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD D. HALL其他文献

EDWARD D. HALL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD D. HALL', 18)}}的其他基金

Nrf2-Antioxidant Response Element Neuroprotection in TBI
Nrf2-抗氧化反应元件在 TBI 中的神经保护作用
  • 批准号:
    9241702
  • 财政年份:
    2016
  • 资助金额:
    $ 32.88万
  • 项目类别:
Carbonyl Scavenging for Traumatic Brain Injury
羰基清除治疗创伤性脑损伤
  • 批准号:
    8993650
  • 财政年份:
    2014
  • 资助金额:
    $ 32.88万
  • 项目类别:
Multi-Mechanism Inhibition of Lipid Peroxidation in TBI
TBI 中脂质过氧化的多机制抑制
  • 批准号:
    9093852
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
Multi-Mechanism Inhibition of Lipid Peroxidation in TBI
TBI 中脂质过氧化的多机制抑制
  • 批准号:
    8870460
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
Multi-Mechanism Inhibition of Lipid Peroxidation in TBI
TBI 中脂质过氧化的多机制抑制
  • 批准号:
    9303474
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
Multi-Mechanism Inhibition of Lipid Peroxidation in TBI
TBI 中脂质过氧化的多机制抑制
  • 批准号:
    8658871
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
Multi-Mechanism Inhibition of Lipid Peroxidation in TBI
TBI 中脂质过氧化的多机制抑制
  • 批准号:
    8602633
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
Inhibition of Lipid Peroxidation in SCI
SCI 中脂质过氧化的抑制
  • 批准号:
    8239698
  • 财政年份:
    2011
  • 资助金额:
    $ 32.88万
  • 项目类别:
Inhibition of Lipid Peroxidation in SCI
SCI 中脂质过氧化的抑制
  • 批准号:
    8333969
  • 财政年份:
    2011
  • 资助金额:
    $ 32.88万
  • 项目类别:
26th National Neurotrauma Symposium, 2008
第26届全国神经创伤研讨会,2008年
  • 批准号:
    7541566
  • 财政年份:
    2008
  • 资助金额:
    $ 32.88万
  • 项目类别:

相似国自然基金

Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
  • 批准号:
    81570922
  • 批准年份:
    2015
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
  • 批准号:
    81171052
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

In vivo anti cancer natural product synthesis based on reaction with endogenous acrolein
基于与内源性丙烯醛反应的体内抗癌天然产物合成
  • 批准号:
    23KJ0944
  • 财政年份:
    2023
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Prodrug Strategy by Diels-Alder Reaction with Cancer-Derived Acrolein
通过与癌症衍生的丙烯醛进行第尔斯-阿尔德反应的前药策略
  • 批准号:
    23K17971
  • 财政年份:
    2023
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy
癌细胞产生的丙烯醛的反应性:在选择性癌症治疗中的应用
  • 批准号:
    21K05269
  • 财政年份:
    2021
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
  • 批准号:
    20K08232
  • 财政年份:
    2020
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vivo Click Reaction of Acrolein: Application to In vivo Synthetic Chemistry and Cancer Imaging
丙烯醛的体内点击反应:在体内合成化学和癌症成像中的应用
  • 批准号:
    18K14341
  • 财政年份:
    2018
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Glial activation induced by unsaturated aldehyde acrolein in diabetic retinopathy
不饱和醛丙烯醛诱导糖尿病视网膜病变中的胶质细胞活化
  • 批准号:
    18K09393
  • 财政年份:
    2018
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of acrolein generation in diabetic retinopathy
糖尿病视网膜病变中丙烯醛的生成机制
  • 批准号:
    17K11442
  • 财政年份:
    2017
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for acrolein, a product of lipid peroxidation
脂质过氧化产物丙烯醛荧光探针的开发
  • 批准号:
    17H06580
  • 财政年份:
    2017
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Role of acrolein in the pathogenesis of diabetic retinopathy
丙烯醛在糖尿病视网膜病变发病机制中的作用
  • 批准号:
    26462657
  • 财政年份:
    2014
  • 资助金额:
    $ 32.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Treatments of Acrolein-induced Cardiotoxicity
丙烯醛引起的心脏毒性的新疗法
  • 批准号:
    8610016
  • 财政年份:
    2013
  • 资助金额:
    $ 32.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了